How Obama's trade deal could cripple the fight against AIDS


AIDS research group amfAR has taken a stand against the Trans-Pacific Partnership (TPP), a 12-nation trade deal for which President Obama hopes to gain "fast-track" authority.
According to a new amfAR report, the TPP's provisions about pharmaceutical companies could increase the cost of drugs in the developing world. The report claims that the trade deal's provisions would hinder AIDS treatment, because it could delay the introduction of generic, lower-cost treatments.
The report suggests the TPP could expand intellectual property protections and expand what qualifies for patents, which "would tilt the playing field in favor of drug companies," Vox explains. The provisions could delay the availability of generic medicines, because during the large companies' patent monopolies over the medicines, other companies couldn't create generic versions.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Vox notes that the TPP could also enforce "data exclusivity," requiring generic producers to conduct their own clinical trials, rather than using data from the large companies' original tests. Conducting additional trials would cost generic producers time and resources, which could also delay generics' introduction into the market.
"The global community would never have achieved its successes in addressing the HIV epidemic if the terms of the proposed TPP were the international standard in 2001," amfAR said in the report, adding that the TPP's provisions "show a disregard for public health."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
-
Alex G, Tyler, the Creator and Jessie Murph
Feature "Headlights," "Don't Tap the Glass" and "Sex Hysteria"
-
7 peaceful, easy hikes across the US
The Week Recommends These trails won't leave you breathless
-
Film reviews: The Fantastic Four: First Steps and Cloud
Feature A space-age superhero team mounts a redo and Reality catches up with an online reseller
-
Senate confirms Trump loyalist Bove to top court
Speed Read The president's former criminal defense lawyer was narrowly approved to earn a lifetime seat
-
Ghislaine Maxwell offers testimony for immunity
Speed Read The convicted sex trafficker offered to testify to Congress about her relationship with late boyfriend Jeffrey Epstein
-
Judge halts GOP defunding of Planned Parenthood
Speed Read The Trump administration can't withhold Medicaid funds from Planned Parenthood, said the ruling
-
Trump contradicts Israel, says 'starvation' in Gaza
Speed Read The president suggests Israel could be doing more to alleviate the suffering of Palestinians
-
Trump executive order targets homeless
Speed Read It will now be easier for states and cities to remove homeless people from the streets
-
Columbia pays $200M to settle with White House
Speed Read The Trump administration accused the school of failing to protect its Jewish students amid pro-Palestinian protests
-
Florida judge and DOJ make Epstein trouble for Trump
Speed Read The Trump administration's request to release grand jury transcripts from the Epstein investigation was denied
-
Trump attacks Obama as Epstein furor mounts
Speed Read The Trump administration accused the Obama administration of 'treasonous' behavior during the 2016 election